FC
RMD icon

Fulcrum Capital’s ResMed RMD Stock Holding History

Fulcrum Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,200
Closed -$230K – 113
2024
Q2 		$230K Hold
1,200
– – 0.05% 102
2024
Q1 		$238K Sell
1,200
-269
-18% -$49.3K 0.06% 107
2023
Q4 		$253K Sell
1,469
-186
-11% -$28.6K 0.07% 100
2023
Q3 		$245K Hold
1,655
– – 0.07% 93
2023
Q2 		$362K Hold
1,655
– – 0.1% 81
2023
Q1 		$362K Sell
1,655
-185
-10% -$40.1K 0.1% 79
2022
Q4 		$383K Hold
1,840
– – 0.11% 76
2022
Q3 		$402K Hold
1,840
– – 0.12% 64
2022
Q2 		$386K Hold
1,840
– – 0.12% 59
2022
Q1 		$446K Sell
1,840
-1,053
-36% -$255K 0.12% 55
2021
Q4 		$754K Hold
2,893
– – 0.16% 54
2021
Q3 		$762K Hold
2,893
– – 0.18% 54
2021
Q2 		$713K Hold
2,893
– – 0.18% 47
2021
Q1 		$561K Hold
2,893
– – 0.16% 52
2020
Q4 		$615K Sell
2,893
-43
-1% -$8.57K 0.18% 43
2020
Q3 		$503K Hold
2,936
– – 0.18% 44
2020
Q2 		$564K Buy
2,936
+43
+1% +$7.04K 0.21% 41
2020
Q1 		$426K Sell
2,893
-607
-17% -$96.7K 0.19% 44
2019
Q4 		$542K Hold
3,500
– – 0.17% 47
2019
Q3 		$473K Buy
+3,500
New +$459K 0.16% 50

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Fulcrum Capital's RMD Position: Q3 2024 in Review

Fulcrum Capital sold out of ResMed (RMD) in Q3 2024, closing a stake of 1,200 shares — an estimated $230K sold.

Fulcrum Capital first reported a position in RMD in Q3 2019 and held it in 20 quarters. The position peaked at $762K in Q3 2021. 801 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

  • Fulcrum Capital reported no remaining ResMed position as of Q3 2024 after selling out during the quarter.
  • Fulcrum Capital sold 1,200 ResMed shares in Q3 2024, an estimated $230K.
  • Fulcrum Capital first reported a position in ResMed in Q3 2019 and held it in 20 quarters.
  • Fulcrum Capital's ResMed position peaked at $762K in Q3 2021.
  • 801 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on Fulcrum Capital's 13F filing for Q3 2024, filed 22 Oct 2024.